Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ardelyx Inc (NQ: ARDX )

4.080 +0.040 (+0.99%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 29, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,895,075
Open 4.070
Bid (Size) 3.950 (1)
Ask (Size) 4.100 (21)
Prev. Close 4.040
Today's Range 3.970 - 4.115
52wk Range 1.110 - 5.125
Shares Outstanding 103,119,010
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Ardelyx Announces Publication of Positive Results from T3MPO-3 Long-Term Open-Label Safety Trial of Tenapanor for IBS-C in the Journal of Neurogastroenterology and Motility
From Ardelyx, Inc.
Via GlobeNewswire
Tenapanor for Hyperphosphatemia Approved in Japan
From Ardelyx, Inc.
Via GlobeNewswire

Performance

YTD
+52.24%
+52.24%
1 Month
-3.77%
-3.77%
3 Month
+20.35%
+20.35%
6 Month
-14.82%
-14.82%
1 Year
+261.06%
+261.06%

More News

Read More
The 3 Best Penny Stocks to Buy Now: September 2023
Via InvestorPlace
Topics Economy
Exposures Economy
Analyst Expectations for Ardelyx's Future
Via Benzinga
Ardelyx Inc. (NASDAQ: ARDX) is a Stock Spotlight on 8/30
Via Investor Brand Network
Earnings Outlook For Ardelyx
Via Benzinga
Ardelyx Showcased Encouraging Data on Treatment Satisfaction and Efficacy of IBSRELA® (tenapanor) for IBS-C at GHAPP 2023
From Ardelyx, Inc.
Via GlobeNewswire
Ardelyx to Present at the H.C. Wainwright 25th Annual Global Investment Conference
From Ardelyx, Inc.
Via GlobeNewswire
Ardelyx, Inc. Reports Employment Inducement Grants
From Ardelyx, Inc.
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2023
Via Benzinga
The 3 Most Promising Penny Stocks to Own Now
Via InvestorPlace
3 Penny Stocks You’ll Regret Not Buying Soon
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2023
Via Benzinga
Hibbett, American Software, Ardelyx And Other Big Stocks Moving Higher On Friday
Via Benzinga
Topics Stocks
Exposures US Equities
Don’t Sleep on These 3 Penny Stocks That Will Mint Millionaires
Via InvestorPlace
5 Meme Stocks to Sell Immediately, According to AI
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
3 Cheap Biotech Stocks That Smart Investors Will Snap Up Now
Via InvestorPlace
Ardelyx Reports Second Quarter 2023 Financial Results and Provides 2023 IBSRELA Net Sales Revenue Guidance
From Ardelyx, Inc.
Via GlobeNewswire
Ardelyx, Inc. Reports Employment Inducement Grants
From Ardelyx, Inc.
Via GlobeNewswire
Ardelyx to Report Second Quarter 2023 Financial Results on August 2, 2023
From Ardelyx, Inc.
Via GlobeNewswire
Ardelyx to Present at the H.C. Wainwright 2nd Annual Kidney Conference
From Ardelyx, Inc.
Via GlobeNewswire
Ardelyx Announces Acceptance of New Drug Application for Tenapanor for Hyperphosphatemia in China
From Ardelyx, Inc.
Via GlobeNewswire
Ardelyx, Inc. Reports Employment Inducement Grants
From Ardelyx, Inc.
Via GlobeNewswire
Leading Proxy Advisory Firms ISS and Glass Lewis Recommend Ardelyx Stockholders Vote in Favor of Proposed Share Increase
From Ardelyx, Inc.
Via GlobeNewswire
Ardelyx to Present at the Jefferies 2023 Healthcare Conference
From Ardelyx, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.